Lexicon Pharmaceuticals, Inc. share price logo

Lexicon Pharmaceuticals, Inc. Share Price

NASDAQ: LXRX

Small Cap

$1.09

-0.01

(-0.45%)

as on

Lexicon Pharmaceuticals, Inc. Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $1.06
    $1.11
    downward going graph

    2.75%

    Downside

    1.83%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.28
    $2.18
    downward going graph

    73.98%

    Downside

    99.54%

    Upside

    downward going graph

Lexicon Pharmaceuticals, Inc. share price movements today

Previous Close
$1.10
Open
$1.09
Volume
2.4M
Day's Low - High
$1.06 - $1.11
52 Week Low - High
$0.28 - $2.18

Lexicon Pharmaceuticals, Inc. Historical Returns

1 Month Return
-9.68 %
3 Month Return
+ 55.43 %
1 Year Return
-30.86 %
3 Year Return
-57.41 %
5 Year Return
-34.12 %

Lexicon Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Check Lexicon Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$399.7M

EPS (TTM)

-0.1864

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.63%

PE Ratio (TTM)

-3.22

Industry PE ratio

-3.9281873111782475

P/B Ratio

0

PEG Ratio

-0.14

EBITDA

-105.5M

Revenue (TTM)

58.4M

Profit Margin

-206.43%

Return On Equity TTM

137467300.00%

Lexicon Pharmaceuticals, Inc. Stock Valuation

Track how Lexicon Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.

Lexicon Pharmaceuticals, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (12.67x)

June 30, 2021

Industry (-3.93x)

September 17, 2025

Today (-3.22x)

September 17, 2025

Highest (12.67x)

June 30, 2021

LowHigh

Today’s Price to Earnings Ratio: -3.22x

Lexicon Pharmaceuticals, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lexicon Pharmaceuticals, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$399.7M-34.12%-3.22-206.43%
BUY$60.5B252.04%-505.15-12.96%
NA$39.0BNANA-3.89%
BUY$100.3B44.17%27.8531.86%
BUY$59.6B1.78%14.131.37%

Stock Returns calculator for Lexicon Pharmaceuticals, Inc. Stock including INR - Dollar returns

The Lexicon Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Lexicon Pharmaceuticals, Inc. investment value today

Current value as on today

₹71,882

Returns

₹28,118

(-28.12%)

Returns from Lexicon Pharmaceuticals, Inc. Stock

₹32,716 (-32.72%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Lexicon Pharmaceuticals, Inc. Stock

Based on 11 analysts

BUY

72.73%

Buy

27.27%

Hold

0.00%

Sell

Based on 11 analysts, 72.73% of analysts recommend a 'BUY' rating for Lexicon Pharmaceuticals, Inc.. Average target price of $2.75

Lexicon Pharmaceuticals, Inc. Share Price Target

Get share price movements and forecasts by analysts on Lexicon Pharmaceuticals, Inc..

What analysts predicted

60.36%UPSIDE

Target Price

$2.75

Current Price

$1.09

Analyzed by

11 Analysts

Target

$2.75

Lexicon Pharmaceuticals, Inc. target price $2.75, a slight upside of 60.36% compared to current price of $1.09. According to 11 analysts rating.

Lexicon Pharmaceuticals, Inc. Stock's Interest Amongst Investors

Search interest for Lexicon Pharmaceuticals, Inc. Stock has decreased by -2% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-2% versus previous 30 day period

Lexicon Pharmaceuticals, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
0
0
0
0
1
1
1
26
1
28
Gross Profit
0
0
0
0
0
1
1
26
1
28
Operating Income
-31
-44
-49
-46
-45
-55
-63
-32
-25
3
EBITDA
-30
-42
-46
-44
-44
-51
-60
-29
-25
5
Interest Expense
1
1
3
5
4
2
4
3
1
2
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-31
-44
-50
-48
-48
-53
-64
-33
-25
3
Income Tax Expense
-1
1
2
-2
0
-
-
0
-
-
Net Income
-30
-44
-50
-48
-48
-53
-64
-33
-25
3
Net Profit Margin
-128770.83%
-14165.30%
-31188.27%
-6872.36%
-4282.92%
-3244.02%
-3703.49%
-127.16%
-2004.36%
11.27%

Lexicon Pharmaceuticals, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
130
83
90
63
322
23
0
0
1
31
Gross Profit
34
-80
88
60
318
22
-54
0
1
30
Operating Income
1
-137
-136
-103
141
-178
-87
-100
-171
-197
EBITDA
11
-125
-125
-96
173
-41
-86
-98
-163
-184
Interest Expense
6
6
6
20
20
14
0
2
13
15
Depreciation
-
-
3
3
3
2
0
0
0
0
Income Before Tax
-4
-141
-141
-120
124
-58
-87
-101
-177
-200
Income Tax Expense
5
4
-12
3
-6
11
0
1
0
-200
Net Income
-4
-141
-129
-120
130
-70
-88
-103
-177
-200
Net Profit Margin
-3.60%
-169.71%
-142.86%
-190.71%
40.40%
-292.49%
-29620.13%
-74192.81%
-14710.88%
-644.78%

Lexicon Pharmaceuticals, Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-44
-50
-48
-48
-53
-64
-33
-25
3
Operating Cash Flow
-38
-41
-50
-55
-48
-53
-21
-43
16
Investing Cash Flow
-74
-39
51
-110
-12
53
53
40
15
Financing Cash Flow
188
0
0
239
0
0
0
0
-45
Change in Cash
76
-81
1
74
-60
-1
32
-3
-12

Lexicon Pharmaceuticals, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-141
-129
-120
130
-58
-87
-101
-177
-200
Operating Cash Flow
-175
-185
-148
113
-142
-87
-88
-161
-178
Investing Cash Flow
18
50
169
-155
380
2
-71
-49
-15
Financing Cash Flow
0
149
-2
-2
-147
22
142
187
238
Change in Cash
-156
15
18
-44
90
-62
-17
-23
44

Global Institutional Holdings in Lexicon Pharmaceuticals, Inc.

Funds
Holdings
Artal Group S A
37.47%
Siren, L.L.C.
10.71%
FMR Inc
9.51%
BlackRock Inc
2.76%
Vanguard Group Inc
2.63%

Insights on Lexicon Pharmaceuticals, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, -64.81M → 3.25M (in $), with an average increase of 334.4% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 1.26M → 28.86M (in $), with an average increase of 95.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 100.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 174.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, LXRX stock has moved down by -11.3%

About Lexicon Pharmaceuticals, Inc.

corporate overview lexicon pharmaceuticals is a biopharmaceutical company that has harnessed the power of genetics for drug discovery. our research team has generated a pipeline of novel drug candidates in clinical development across a broad range of indications. the genome: our source of discovery we have applied gene knockout technology to thousands of potential drug targets encoded in the human genome. our scientists have gained a thorough understanding of target biology and identified new points of intervention for future therapies. we have integrated a series of recombinant dna and chemistry technologies into a systematic drug discovery and development process. our unique knowledge of targets from the human genome has allowed us to better evaluate and advance novel drug candidates with great promise for patients. a diverse pipeline of targeted therapies our genomics-based approach to drug discovery has enabled our scientists to select drug targets across a broad range of indicatio
OrganisationLexicon Pharmaceuticals, Inc.
Headquarters2445 Technology Forest Boulevard, The Woodlands, TX, United States, 77381
IndustryHealth Technology
CEODr. Michael S. Exton Ph.D.
E-voting on sharesClick here to vote

Key Management of Lexicon Pharmaceuticals, Inc.

Name

Title

Ms. Desiree Gendron

Vice President of Sales & Training

Ms. Wendy E. McDermott

Senior Vice President of Human Resources

Dr. Craig B. Granowitz M.D., Ph.D.

Senior VP & Chief Medical Officer

Ms. Kristen L. Alexander

Vice President of Finance & Accounting

Mr. Brian T. Crum

Senior VP, General Counsel & Secretary

Mr. Scott M. Coiante

Senior VP & CFO

Ms. Lisa M. DeFrancesco

Senior Vice President of Investor Relations & Corporate Communications

Mr. Dixon Terry

Vice President of Compliance

Ms. Carrie Siragusa

Vice President of Marketing

Dr. Michael S. Exton Ph.D.

CEO & Director

FAQs

What is Lexicon Pharmaceuticals, Inc. share price today?

Lexicon Pharmaceuticals, Inc. share price today is $1.09 as on at the close of the market. Lexicon Pharmaceuticals, Inc. share today touched a day high of $1.11 and a low of $1.06.

What is the 52 week high and 52 week low for Lexicon Pharmaceuticals, Inc. share?

Lexicon Pharmaceuticals, Inc. share touched a 52 week high of $2.18 on and a 52 week low of $0.28 on . Lexicon Pharmaceuticals, Inc. stock price today i.e. is closed at $1.09,which is 49.89% down from its 52 week high and 284.34% up from its 52 week low.

What is Lexicon Pharmaceuticals, Inc.'s market capitalisation today?

Lexicon Pharmaceuticals, Inc. market capitalisation is $0.00T as on .

How to invest in Lexicon Pharmaceuticals, Inc. Stock (LXRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lexicon Pharmaceuticals, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lexicon Pharmaceuticals, Inc. Shares that will get you 1.3761 shares as per Lexicon Pharmaceuticals, Inc. share price of $1.09 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Lexicon Pharmaceuticals, Inc. Stock (LXRX) from India?

Indian investors can start investing in Lexicon Pharmaceuticals, Inc. (LXRX) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Lexicon Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Lexicon Pharmaceuticals, Inc. share’s latest price of $1.09 as on September 18, 2025 at 1:29 am IST, you will get 9.1743 shares of Lexicon Pharmaceuticals, Inc.. Learn more about fractional shares .

What are the returns that Lexicon Pharmaceuticals, Inc. has given to Indian investors in the last 5 years?

Lexicon Pharmaceuticals, Inc. stock has given -34.12% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?